SCHEMBL21591730

SCHEMBL21591730

COc1cc(CCO[C@@H]2CCCCO2)c(CCNC(=O)OC(C)(C)C)cn1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
KDM4C Q9H3R0 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.38
MTNR1A P48039 2/20 0.37
MTNR1B P49286 2/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
EPHX1 P07099 1/20 0.35
NQO2 P16083 1/20 0.35
ATR Q13535 3/20 0.35
HPGD P15428 1/20 0.35
KDM4E B2RXH2 1/20 0.34
MAPT P10636 1/20 0.34
HTT P42858 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
FPR3 P25089 2/20 0.33
FPR2 P25090 2/20 0.33
DYRK1A Q13627 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29872603 0.83 MTNR1A (0.36) NPC1RAB9AMTNR1AMTNR1BMEN1
SCHEMBL21594080 0.83 MTNR1A (0.36) NPC1RAB9AMTNR1AMTNR1BMEN1
SCHEMBL21591747 0.79 MTNR1B (0.46) MTNR1AMTNR1BNQO2MAPTHTT
SCHEMBL21591739 0.78 MTNR1B (0.41) MTNR1AMTNR1BNQO2HPGDMAPT
SCHEMBL21591617 0.78 NPC1 (0.49) NPC1RAB9AKDM4CL3MBTL1MEN1
SCHEMBL21591631 0.76 NPC1 (0.52) NPC1RAB9AKDM4CL3MBTL1MEN1
SCHEMBL3959022 0.75 EPHX1 (0.51) MEN1KMT2AEPHX1ATRHTT
SCHEMBL23854684 0.74 MTNR1B (0.46) MTNR1AMTNR1BNQO2MAPTHTT
SCHEMBL30570606 0.73 MTNR1B (0.48) MTNR1AMTNR1BNQO2MAPTHTT
SCHEMBL23854724 0.73 MTNR1B (0.48) MTNR1AMTNR1BNQO2MAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3807270-A1 NOVEL HETEROARYL HETEROCYCLYL COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE F. Hoffmann-La Roche AG (CH) 2021-04-21 EP disclosed
WO-2019238616-A1 NOVEL HETEROARYL HETEROCYCLYL COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE F. HOFFMANN-LA ROCHE AG (CH) 2019-12-19 WO disclosed